SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer combo study halted early
Disease control TerminatedThis study tested a new drug called OC-001, given alone or with an immunotherapy drug (Avelumab), in people with advanced cancers that had spread. The goal was to check safety and how the drug moves through the body. The study was stopped early and involved 73 participants with v…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated May 17, 2026 01:02 UTC
-
Experimental combo for head and neck cancer shows promise but study halted early
Disease control TerminatedThis study tested a new drug called SAR444245 combined with other cancer treatments for people with advanced head and neck cancer that had spread or come back. The goal was to see if the combination could shrink tumors. The study was stopped early, so results are limited. It incl…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 17, 2026 00:58 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-phase study tested a new drug called QEQ278 in 30 adults with advanced lung, kidney, esophageal, or head and neck cancers that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. The trial was terminated early, so…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug combo aims to boost head and neck cancer treatment
Disease control TerminatedThis study tested a new drug called xevinapant combined with chemotherapy and radiation for people with head and neck cancer who cannot take the standard drug cisplatin. The goal was to find the safest dose and see how well the combination works. The study was stopped early, but …
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
Cancer center tests new drug cocktail for Tough-to-Treat head and neck tumors
Disease control TerminatedThis study tested whether adding an experimental drug called magrolimab to standard cancer drugs could help control advanced head and neck cancer. It aimed to see if this combination could shrink tumors and was safe for patients. The trial was for adults whose cancer had returned…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 06, 2026 14:17 UTC
-
Jaw-Saving strategy: Pre-Marking implant sites may shield cancer patients from radiation damage
Knowledge-focused TerminatedThis study looked at whether marking where dental implants will go before starting radiation therapy can protect the jawbone in people with head and neck cancer. Eight patients were included, and researchers checked if this approach kept the implant areas safe from high radiation…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: NA • Sponsor: Institut de cancérologie Strasbourg Europe • Aim: Knowledge-focused
Last updated May 17, 2026 00:53 UTC